Latest Grifols News & Updates

See the latest news and media coverage for Grifols. We track all announcements, press releases, and industry mentions in real time, all in one place.

Grifols

Global healthcare company providing plasma-derived medicines, diagnostics, and transfusion solutions

grifols.com

Headquarters: Sant Cugat del Vallès, Spain
Founded year: 1909
Company type: Public company
Number of employees: 14,000+
Industry: Pharmaceuticals

Last updated Today

Latest news about Grifols

In short: Grifols posted solid first-half results and refinanced debt, while facing a Canadian plasma safety crisis.

Company announcements

August 10 Grifols

Grifols completes phase 3 SPARTA study

The study evaluated emphysema due to alpha-1 antitrypsin deficiency and is the largest randomized, double-blind, placebo-controlled augmentation therapy study in this population.

July 30 Grifols

Grifols appoints new board member after resignation

Joanna Susan Le Couilliard replaces Iñigo Sánchez-Asiaín Mardones as independent director and Audit Committee Chair

July 28 Grifols

Grifols reported solid first half 2026 results

Revenue grew from immunoglobulins, debt refinanced, organizational transformation advanced.

July 28 Grifols

Grifols reports 2.6% revenue growth and 28.7% net profit rise

Adjusted EBITDA reached €854 million with margin improvement, and free cash flow pre-M&A turned positive to €91 million.

Media coverage

Today MSN

Europe investigates Grifols's immunoglobulins after the withdrawal of at least 27 batches in the US and the EU

The European Medicines Agency (EMA) has opened an investigation into the safety of normal human immunoglobulins after detecting an increase in the...

October 28 Cinco Días

Gotham manages to suspend Grifols' lawsuit in New York while the court studies jurisdiction

The judge states that the temporary halt of the information exchange phase to prepare for the trial causes no harm...

October 20 El Economista

Grifols faces the recall of five batches of immunoglobulins in the United States

Grifols faces a new health alert in the United States that could slow sales of its plasma-derived medicines in its main market of...

October 2 Cinco Días

Gotham puts Grifols' lawsuit in New York on hold after more than two years of litigation

The bassist's defense, which has just been reinforced with a new law firm, warns that the court lacks jurisdiction because Daniel Yu is...

Never miss news about Grifols

Track Grifols and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.